-
-
-
-
-
-
-
Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSECĀ® (secnidazole) for the Treatment of Trichomoniasis
-
-
-
-
-
-
-
Lupin Acquires Specialty Product Portfolio in Germany
-
-
-
1,157,630 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

